Euclidean Fund For Cancer Research LP — Form D
Euclidean Fund For Cancer Research LP of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2018-05-01. $3.7M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2018-05-01
- Form: D
- Accession: 0000919574-18-003237
- Industry: Pooled Investment Fund
- Exemptions: 06c, 3C, 3C.1
- Amount sold: $3.7M
- Investors: 8
- Date of first sale: 2018-05-01
- Security types: equity, fund interests
- SEC file number: 021-311389
Issuer
- Name: Euclidean Fund For Cancer Research LP
- CIK: 0001729236
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: EUCLIDEAN TECHNOLOGIES GP, LLC 1325 AVENUE OF THE AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Phone: 646-571-1670
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| -- Euclidean Technologies GP, LLC | Executive Officer | Seattle, WA |
| -- Euclidean Technologies GP, LLC | Promoter | Seattle, WA |
| -- Euclidean Technologies Management, LLC | Executive Officer | Seattle, WA |
| -- Euclidean Technologies Management, LLC | Promoter | Seattle, WA |
Other filings by this issuer (5)
More